Synlogic to Webcast Presentation at the SVB Leerink 8th Annual Global Healthcare Conference
February 20 2019 - 4:02PM
Business Wire
Synlogic (Nasdaq:SYBX) announced today that Aoife Brennan, M.B.,
B.Ch., Synlogic’s president and chief executive officer, will
provide a corporate update at the SVB Leerink 8th Annual Global
Healthcare Conference at 1:30 pm ET on Thursday, February 28, 2019,
in New York City.
A live webcast of the presentation can be accessed under “Event
Calendar” in the Investors & Media section of the Company’s
website. An archive copy of the webcast will be available on the
Synlogic website for approximately 30 days after the event.
About SynlogicSynlogic is pioneering the development of a
novel class of living medicines, Synthetic Biotic medicines, based
on its proprietary drug development platform. Synlogic leverages
the tools and principles of synthetic biology to genetically
engineer beneficial microbes to perform or deliver critical
functions missing or damaged due to disease. Synthetic Biotic
medicines are designed to act locally and have a systemic effect to
address disease in patients. Synlogic’s two lead programs, SYNB1020
and SYNB1618, are orally administered and target hyperammonemia as
a result of liver damage or genetic disease, and phenylketonuria,
respectively. Synlogic is also developing SYNB1891 as an
intratumorally administered Synthetic Biotic medicine for the
treatment of cancer. In addition, the company is leveraging the
broad potential of its platform to create additional Synthetic
Biotic medicines for the treatment of liver disease, as well as
inflammatory and immune disorders, including Synlogic’s
collaboration with AbbVie to develop Synthetic Biotic-based
treatments for inflammatory bowel disease (IBD). For more
information, please visit www.synlogictx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190220005878/en/
MEDIA CONTACT:SynlogicCourtney HeathPhone:
617-872-2462Email: courtney@scientpr.comINVESTOR
CONTACT:SynlogicElizabeth Wolffe, Ph.D.Phone:
617-207-5509Email: liz@synlogictx.com
Synlogic (NASDAQ:SYBX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Synlogic (NASDAQ:SYBX)
Historical Stock Chart
From Apr 2023 to Apr 2024